The Procter & Gamble Company Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- The Procter & Gamble Company payments for repurchase of common stock for the quarter ending 2026-06-30 was $875.00M, a 25.00% increase year-over-year.
- The Procter & Gamble Company payments for repurchase of common stock for the quarter ending 2026-03-31 was $625.00M, a 53.74% decline year-over-year.
- The Procter & Gamble Company payments for repurchase of common stock for the quarter ending 2025-12-31 was $2.28B, a 9.24% decline year-over-year.
- The Procter & Gamble Company payments for repurchase of common stock for the quarter ending 2025-09-30 was $1.25B, a 35.53% decline year-over-year.
- The Procter & Gamble Company payments for repurchase of common stock for fiscal 2026 was $5.03B, a 22.65% decline from fiscal 2025.
- The Procter & Gamble Company payments for repurchase of common stock for fiscal 2025 was $6.50B, a 29.84% increase from fiscal 2024.
- The Procter & Gamble Company payments for repurchase of common stock for fiscal 2024 was $5.01B, a 31.92% decline from fiscal 2023.
- The Procter & Gamble Company payments for repurchase of common stock for fiscal 2023 was $7.35B, a 26.49% decline from fiscal 2022.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-06-30 | $875.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-04 | $5.03B 10-K · filed 2026-08-04 |
| 2026-03-31 | $625.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-24 | $4.85B derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $2.28B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-23 | $5.58B derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-09-30 | $1.25B 10-Q · filed 2025-10-24 | $5.81B derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $700.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-04 | $6.50B 10-K · filed 2026-08-04 |
| 2025-03-31 | $1.35B derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-24 | $7.32B derived: sum of 4 quarters · filed 2026-08-04 |
| 2024-12-31 | $2.51B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-23 | $6.95B derived: sum of 4 quarters · filed 2026-08-04 |
| 2024-09-30 | $1.94B 10-Q · filed 2025-10-24 | $5.45B derived: sum of 4 quarters · filed 2026-08-04 |
| 2024-06-30 | $1.52B derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-04 | $5.01B 10-K · filed 2026-08-04 |
| 2024-03-31 | $987.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-24 | $3.49B derived: sum of 4 quarters · filed 2025-08-04 |
| 2023-12-31 | $1.00B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-22 | $3.85B derived: sum of 4 quarters · filed 2025-08-04 |
| 2023-09-30 | $1.50B 10-Q · filed 2024-10-18 | $4.85B derived: sum of 4 quarters · filed 2025-08-04 |
| 2023-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-04 | $7.35B 10-K · filed 2025-08-04 |
| 2023-03-31 | $1.35B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-19 | $8.60B derived: sum of 4 quarters · filed 2024-08-05 |
| 2022-12-31 | $2.00B derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-23 | $8.50B derived: sum of 4 quarters · filed 2024-08-05 |
| 2022-09-30 | $4.00B 10-Q · filed 2023-10-18 | $11.25B derived: sum of 4 quarters · filed 2024-08-05 |
| 2022-06-30 | $1.25B derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-05 | $10.00B 10-K · filed 2024-08-05 |
| 2022-03-31 | $1.25B derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-21 | $11.75B derived: sum of 4 quarters · filed 2023-08-04 |
| 2021-12-31 | $4.75B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-19 | $13.51B derived: sum of 4 quarters · filed 2023-08-04 |
| 2021-09-30 | $2.75B 10-Q · filed 2022-10-19 | $11.76B derived: sum of 4 quarters · filed 2023-08-04 |
| 2021-06-30 | $3.00B derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-04 | $11.01B 10-K · filed 2023-08-04 |
| 2021-03-31 | $3.00B derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-20 | $8.01B derived: sum of 4 quarters · filed 2022-08-05 |
| 2020-12-31 | $3.01B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-01-19 | $5.91B derived: sum of 4 quarters · filed 2022-08-05 |
| 2020-09-30 | $2.00B 10-Q · filed 2021-10-19 | $6.41B derived: sum of 4 quarters · filed 2022-08-05 |
| 2020-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-05 | $7.41B 10-K · filed 2022-08-05 |
| 2020-03-31 | $901.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-20 | $9.15B derived: sum of 4 quarters · filed 2021-08-06 |
| 2019-12-31 | $3.50B derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-20 | $9.50B derived: sum of 4 quarters · filed 2021-08-06 |
| 2019-09-30 | $3.00B 10-Q · filed 2020-10-20 | $6.75B derived: sum of 4 quarters · filed 2021-08-06 |
| 2019-06-30 | $1.75B derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-06 | $5.00B 10-K · filed 2021-08-06 |
| 2019-03-31 | $1.25B derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-20 | $4.62B derived: sum of 4 quarters · filed 2020-08-07 |
| 2018-12-31 | $751.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-23 | $4.75B derived: sum of 4 quarters · filed 2020-08-07 |
| 2018-09-30 | $1.25B 10-Q · filed 2019-10-22 | $5.75B derived: sum of 4 quarters · filed 2020-08-07 |
| 2018-06-30 | $1.37B derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-07 | $7.00B 10-K/A · filed 2020-08-07 |
| 2018-03-31 | $1.38B derived: 10-Q 9 month − 10-Q 6 month · filed 2019-04-23 | $6.33B derived: sum of 4 quarters · filed 2019-08-06 |
| 2017-12-31 | $1.75B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-01-23 | $6.95B derived: sum of 4 quarters · filed 2019-08-06 |
| 2017-09-30 | $2.50B 10-Q · filed 2018-10-19 | $6.70B derived: sum of 4 quarters · filed 2019-08-06 |
| 2017-06-30 | $700.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-06 | $5.20B 10-K · filed 2019-08-06 |
| 2017-03-31 | $2.00B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-19 | $5.00B derived: sum of 4 quarters · filed 2018-10-22 |
| 2016-12-31 | $1.50B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-23 | $4.00B derived: sum of 4 quarters · filed 2018-10-22 |
| 2016-09-30 | $1.00B 10-Q · filed 2017-10-20 | $4.50B derived: sum of 4 quarters · filed 2018-10-22 |
| 2016-06-30 | $500.00M derived: 8-K 12 month − 10-Q 9 month · filed 2018-10-22 | $4.00B 8-K · filed 2018-10-22 |
| 2016-03-31 | $1.00B derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-26 | $3.85B derived: sum of 4 quarters · filed 2017-08-07 |
| 2015-12-31 | $2.00B derived: 10-Q 6 month − 10-Q 3 month · filed 2017-01-20 | $2.85B derived: sum of 4 quarters · filed 2017-08-07 |
| 2015-09-30 | $502.00M 10-Q · filed 2016-10-25 | $2.73B derived: sum of 4 quarters · filed 2017-08-07 |
| 2015-06-30 | $350.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-07 | $4.60B 10-K · filed 2017-08-07 |
| 2015-03-31 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-04-26 | $4.75B derived: sum of 4 quarters · filed 2016-08-09 |
| 2014-12-31 | $1.88B derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-26 | $6.25B derived: sum of 4 quarters · filed 2016-08-09 |
| 2014-09-30 | $2.38B 10-Q · filed 2015-10-23 | $5.88B derived: sum of 4 quarters · filed 2016-08-09 |
| 2014-06-30 | $500.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-09 | $6.00B 10-K · filed 2016-08-09 |
| 2014-03-31 | $1.50B derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-23 | $6.51B derived: sum of 4 quarters · filed 2015-10-26 |
| 2013-12-31 | $1.50B derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-27 | $6.01B derived: sum of 4 quarters · filed 2015-10-26 |
| 2013-09-30 | $2.50B 10-Q · filed 2014-10-24 | $5.90B derived: sum of 4 quarters · filed 2015-10-26 |
| 2013-06-30 | $1.00B derived: 8-K 12 month − 10-Q 9 month · filed 2015-10-26 | $5.99B 8-K · filed 2015-10-26 |
| 2013-03-31 | $1.00B derived: 10-Q 9 month − 10-Q 6 month · filed 2014-04-23 | $4.99B derived: sum of 4 quarters · filed 2014-08-08 |
| 2012-12-31 | $1.40B derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-24 | $6.24B derived: sum of 4 quarters · filed 2014-08-08 |
| 2012-09-30 | $2.58B 10-Q · filed 2013-10-25 | $5.35B derived: sum of 4 quarters · filed 2014-08-08 |
| 2012-06-30 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-08 | $4.02B 10-K · filed 2014-08-08 |
| 2012-03-31 | $2.26B derived: 10-Q 9 month − 10-Q 6 month · filed 2013-04-24 | $6.53B derived: sum of 4 quarters · filed 2013-10-28 |
| 2011-12-31 | $503.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-01-25 | $5.28B derived: sum of 4 quarters · filed 2013-10-28 |
| 2011-09-30 | $1.26B 10-Q · filed 2012-10-25 | $5.29B derived: sum of 4 quarters · filed 2013-10-28 |
| 2011-06-30 | $2.50B derived: 8-K 12 month − 10-Q 9 month · filed 2013-10-28 | $7.04B 8-K · filed 2013-10-28 |
| 2011-03-31 | $1.01B derived: 10-Q 9 month − 10-Q 6 month · filed 2012-04-27 | $7.12B derived: sum of 4 quarters · filed 2012-08-08 |
| 2010-12-31 | $518.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-01-27 | $8.12B derived: sum of 4 quarters · filed 2012-08-08 |
| 2010-09-30 | $3.01B 10-Q · filed 2011-10-27 | $9.01B derived: sum of 4 quarters · filed 2012-08-08 |
| 2010-06-30 | $2.59B derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-08 | $6.00B 10-K · filed 2012-08-08 |
| 2010-03-31 | $2.00B derived: 10-Q 9 month − 10-Q 6 month · filed 2011-04-29 | $3.42B derived: sum of 4 quarters · filed 2012-02-10 |
| 2009-12-31 | $1.41B derived: 10-Q 6 month − 10-Q 3 month · filed 2011-01-28 | $2.54B derived: sum of 4 quarters · filed 2012-02-10 |
| 2009-09-30 | $8.00M 10-Q · filed 2010-10-28 | $2.47B derived: sum of 4 quarters · filed 2012-02-10 |
| 2009-06-30 | $5.00M derived: 8-K 12 month − 10-Q 9 month · filed 2012-02-10 | $6.37B 8-K · filed 2012-02-10 |
| 2009-03-31 | $1.12B derived: 10-Q 9 month − 10-Q 6 month · filed 2010-04-30 | |
| 2008-12-31 | $1.33B derived: 10-Q 6 month − 10-Q 3 month · filed 2010-01-28 | |
| 2008-09-30 | $3.91B 10-Q · filed 2009-10-29 | |
| 2008-06-30 | $10.05B 10-K · filed 2010-08-13 | |
| 2007-06-30 | $5.58B 8-K · filed 2010-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| Longevity Health Holdings, Inc. (XAGE) | United States | $0.006B | -0.09 |